|
Volumn 44, Issue 1 SUPPL. 2, 2013, Pages
|
Pre-exposure prophylaxis for HIV: Can it be implemented in the real world?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
BUPRENORPHINE;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
ANTIHYPERTENSIVE THERAPY;
ANTIVIRAL THERAPY;
CLINICAL PRACTICE;
DISEASE TRANSMISSION;
FOLLOW UP;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE ACCESS;
HEALTH CARE COST;
HEALTH PROGRAM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NOTE;
SEROCONVERSION;
ANTI-HIV AGENTS;
DEOXYCYTIDINE;
DIFFUSION OF INNOVATION;
DRUG COMBINATIONS;
HEALTH PLAN IMPLEMENTATION;
HIV INFECTIONS;
HUMANS;
ORGANOPHOSPHORUS COMPOUNDS;
PRIMARY PREVENTION;
|
EID: 84871788438
PISSN: 07493797
EISSN: 18732607
Source Type: Journal
DOI: 10.1016/j.amepre.2012.10.004 Document Type: Note |
Times cited : (8)
|
References (8)
|